Newsy's Latest Health News

The video discusses the FDA's anticipated authorization of Moderna's COVID-19 vaccine for emergency use, following a recommendation from an advisory panel. This would make it the second vaccine available in the US after Pfizer's. Additionally, Johnson & Johnson is conducting a large-scale vaccine trial and expects interim data by January, with plans to seek emergency use authorization if results are favorable. The video concludes with acknowledgments to Kaiser Health News for their contributions.

What will Johnson and Johnson do if the interim data from their trial looks good?

What event caused Johnson and Johnson to briefly pause their trial in the US?